Médecins pour Métastases dans le foie à l'étranger — Page 3

Le professeur agrégé Tahsin Ozatli est spécialisé dans les cancers du sein, du poumon et gastro-intestinaux à l'hôpital universitaire Istinye Liv.

• Plus d'une décennie d'expérience en oncologie
• Travailler à la clinique d'oncologie d'Ankara et à l'hôpital régional de formation et de recherche d'Erzurum
• Nommer professeur agrégé en 2016

Plus de 30 ans de spécialisation en virothérapie – Le Dr Jaunalksne apporte des approches immunologiques de pointe pour traiter les métastases hépatiques à la Pallas Clinic.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne
• Se concentrer sur les traitements d'immunothérapie innovants

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Atakan Topcu is a medical oncologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating solid tumors including lung, breast, and colorectal cancers. Dr. Topcu is an Associate Professor with over 50 peer-reviewed scientific publications. He sits on the Editorial Board of the medical journal BMC Cancer.

• Expertise in immunotherapy, targeted therapies, and geriatric oncology care.
• Treats cancer-related malnutrition, cachexia, and sarcopenia.
• Maintains active membership in the European Society for Medical Oncology (ESMO).
• Works at a JCI-accredited hospital specializing in advanced oncology treatments.

Spécialisé en oncologie médicale avec une formation à l'Université Akdeniz – le Dr Alemdar se concentre sur les métastases hépatiques au Medical Park Antalya.

• Formé en médecine interne avant de se spécialiser en oncologie
• Expérience dans plusieurs hôpitaux de premier plan, dont l'Université Akdeniz
• Poste actuel au complexe hospitalier Medical Park Antalya
• Membre d'associations professionnelles d'oncologie

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Spécialisé en chirurgie laparoscopique des métastases hépatiques – formé dans les meilleurs programmes de l'Université d'Istanbul.

• Plus de 30 ans d'expérience en chirurgie générale et laparoscopique
• Formation avancée en chirurgie laparoscopique bariatrique et oncologique
• Membre de l'Association Turque de Chirurgie

Le professeur Gul Alco allie plus de 25 ans d'expérience en oncologie radiothérapique à un leadership académique dans les meilleures universités turques.

• Spécialisé dans le traitement des métastases hépatiques par des techniques de radiation précises
• Professeur au département d'oncologie radiothérapique de l'université Medipol d'Istanbul
• Formé à l'université d'Istanbul – la principale faculté de médecine de Turquie
• Concilier la pratique clinique et l'enseignement aux futurs radio-oncologues

Le Prof. associé Nail Paksoy est spécialisé dans le traitement des métastases hépatiques à l'hôpital Medipol Bahçelievler, avec des recherches approfondies en oncologie.

• Certifié par l'ESMO en oncologie médicale
• Participation à de multiples essais cliniques internationaux pour les traitements du cancer
• Publication de nombreux articles sur les cancers métastatiques
• Formation spécialisée (Fellowship) à l'Institut d'oncologie de l'Université d'Istanbul

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Spécialisé dans les chirurgies oncologiques complexes, y compris les métastases hépatiques, aux hôpitaux Büyük Anadolu.

• Expert en chirurgies du pancréas et des voies biliaires
• Compétent en chirurgies oncologiques et mammaires
• Expérimenté dans les interventions pour le cancer de l'estomac et du côlon
• Réaliser des chirurgies du cancer de la thyroïde et de l'obésité

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Le professeur Rifaat Safadi dirige l'unité des maladies du foie au centre médical Hadassah, se spécialisant dans les traitements hépatiques avancés avec une reconnaissance internationale.

• Formé auprès du professeur Scott Friedman à la Sinai School of Medicine de New York
• Membre d'associations internationales pour l'étude du foie
• Récompensé pour ses recherches sur la modulation immunitaire de la fibrose hépatique
• Auteur de nombreux articles en hépatologie
• Chef de l'unité des maladies du foie au centre médical Hadassah